Phase II Open-Label Study to Assess Efficacy and Safety of Lenalidomide in Combination with Cetuximab in KRAS-Mutant Metastatic Colorectal Cancer
暂无分享,去创建一个
E. Van Cutsem | J. Tabernero | S. Tejpar | K. Bencardino | A. Sartore-Bianchi | S. Siena | T. Shi | H. Prenen | M. E. Elez | A. Romano | A. Gandhi | U. Jungnelius | M. Sanchis | R. Beck | Mingyu Li | Robert Beck